We also performed qRT-PCR on two genes (ACER2 and CHRM3), which have been found to increase in patients with COPD with/without emphysema in our previous study, and these genes showed no significant difference between the two groups in the validation. The gene discussed is ACER2; the disease is pulmonary emphysema.